Get the latest tech news
Polylaminin, a drug considered capable of reversing spinal cord injury
Patients regained movement in the experimental phase of polylaminin, capable of regenerating the spinal cord in people who suffered organ rupture
From a tender wrapper of human life, the placenta, comes the extraction of a protein that points to a solution for something that, until now, science had no clear path to—and never one so celebrated: restoring the spinal cord in people who suffered injuries and lost body movement. Brazilian researcher Tatiana Coelho de Sampaio, PhD professor at the Federal University of Rio de Janeiro, has quietly worked with a team of biologists for the past 25 years on the repairing and multiplying power of the protein laminin, which acts on the nervous system. During the experimental phase of the antidote, which is applied directly to the spine, patients experienced full recovery of their conditions, with no aftereffects and resuming a routine without restrictions.
Or read this on r/technology
